1. Ranke MB, Blum WF, Bierich JR. Clinical relevance of serum measurements of insulin-like growth factors and somatomedin binding proteins. Acta Paediatr Scand (Suppl) 1988; 347: 114–126.
2. Rosenfeld RG, Wilson DM, Lee PDK, Hintz RL. Insulin-like growth factors I and II in evaluation of fetal growth retardation. J Pediatr 1986; 109: 428–433.
3. Underwood LE and Van Wyk JJ. Normal and Aberrant Growth, in Williams Textbook of Endocrinology (Foster DW, Wilson JP,), 8th Ed. Philadelphia, WB Saunders, 1991; pp. 1079–1138.
4. Blum WF, Albertsson-Wikland K, Rosberg S, Ranke MB. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab 1993; 76: 1610–1616.
5. Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, Muller J, Shakkebaek NE. Serum levels of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) in healthy infants, children and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995; 80: 2534–2542.